India’s Medical Tourism Startups: Funding Gap in $22B Market

India’s medical tourism sector, poised for significant expansion, faces a paradox: its specialized startups have only secured $9.28 million across 18 funding rounds. This comes despite the market’s projection to exceed $22 billion by 2031.

Market Momentum & Policy Tailwinds

The sector’s growth trajectory is undeniable, with the market estimated to reach $12.3 billion in 2026. Foreign medical arrivals have surged from 180,000 in 2020 to over 640,000 in 2024, demonstrating robust demand.

• Government initiatives include expanding e-Medical Visas to 167 countries.
• The ‘Heal in India’ campaign further supports this growth.

Key Players & Patient Demand

A new wave of startups has emerged, providing end-to-end services for international patients. These offerings span from hospital selection and consultations to visas, travel, accommodation, and crucial post-treatment care.

• Companies like Vaidam Health report substantial patient inquiries.
• The Medical Travel Company and CureMeAbroad also show revenue growth.
• These platforms often focus on high-ticket and complex medical cases.

While traditional markets in Africa and the Middle East remain crucial, demand is expanding significantly. The UK, US, and Australia are increasingly looking towards India for medical solutions.

• Long waiting times in the UK’s NHS drive patients abroad.
• High procedure costs in developed markets make India an attractive alternative.
• One UK patient saved considerably on knee treatment in India.

Funding Hurdles & Investor Caution

Despite this clear market potential and the rapid scaling seen in some operations, venture capital has largely remained on the sidelines. The sector has collectively raised a mere $9.28 million.

• Only $9.28 million has been raised across 18 funding rounds.
• This funding has been distributed among 122 medical tourism startups.
• Investors cite the asset-light service model as a key deterrent.
• The model is perceived to limit value creation beyond a certain scale.

Experts suggest this funding dynamic could shift if models evolve into B2B2C businesses, incorporating greater aftercare revenue streams. Such an evolution might position some providers as attractive acquisition targets for larger hospitals.